U.K. Drug Spending Plan Balances 5% Cut With Increased Access
Executive Summary
The U.K. National Health Service could save approximately £310 million in branded drug costs in 2009 under a preliminary agreement between the government and the pharmaceutical industry
You may also be interested in...
Irish Regulator Backs Generic Substitution To Improve Access to New Medicines
Irish Medicines Board surveys patients' views on generic substitution and releases information leaflet.
U.K. Seeks Flexible Drug Pricing; NICE Becomes Flexible On Value
The British government and pharmaceutical industry are negotiating a pricing system that allows the National Health Service to pay more for a drug as its value is demonstrated in clinical practice
U.K. Seeks Flexible Drug Pricing; NICE Becomes Flexible On Value
The British government and pharmaceutical industry are negotiating a pricing system that allows the National Health Service to pay more for a drug as its value is demonstrated in clinical practice